|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2000//527 $5.00
The Journal of Cell Biology, Volume 150, Number 3,
, 2000 527-538
Original Article |
Three Regions within Acta Promote Arp2/3 Complex-Mediated Actin Nucleation and Listeria monocytogenes Motility
welch{at}socrates.berkeley.edu
The Listeria monocytogenes ActA protein induces actin-based motility by enhancing the actin nucleating activity of the host Arp2/3 complex. Using systematic truncation analysis, we identified a 136-residue NH2-terminal fragment that was fully active in stimulating nucleation in vitro. Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host WASP family proteins: an acidic stretch, an actin monomer–binding region, and a cofilin homology sequence. To determine the contribution of each region to actin-based motility, we compared the biochemical activities of ActA derivatives with the phenotypes of corresponding mutant bacteria in cells. The acidic stretch functions to increase the efficiency of actin nucleation, the rate and frequency of motility, and the effectiveness of cell–cell spread. The monomer-binding region is required for actin nucleation in vitro, but not for actin polymerization or motility in infected cells, suggesting that redundant mechanisms may exist to recruit monomer in host cytosol. The cofilin homology sequence is critical for stimulating actin nucleation with the Arp2/3 complex in vitro, and is essential for actin polymerization and motility in cells. These data demonstrate that each region contributes to actin-based motility, and that the cofilin homology sequence plays a principal role in activation of the Arp2/3 complex, and is an essential determinant of L. monocytogenes pathogenesis.
Key Words: bacteria pathogenesis cell movement cytoskeleton microfilament proteins
© 2000 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
The bacterial cell surface protein ActA is necessary and sufficient for actin-based motility in host cytosol (Domann et al. 1992; Kocks et al. 1992; Pistor et al. 1994; Smith et al. 1995; Cameron et al. 1999). ActA can be divided into three domains that have distinct functions. The COOH-terminal domain (amino acids 391–639) contains a transmembrane sequence that is essential for anchoring ActA to the bacterial surface. The central domain (amino acids 264–390) contains four proline-rich repeats that bind to Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family proteins (Chakraborty et al. 1995; Gertler et al. 1996; Smith et al. 1996), which in turn bind to actin filaments (Reinhard et al. 1992; Bachmann et al. 1999) and the actin-binding protein profilin (Reinhard et al. 1995). The central domain is not required for actin-based motility, but contributes to the rate of movement and the percentage of moving bacteria (Lasa et al. 1995; Pistor et al. 1995; Smith et al. 1996). In contrast, the mature NH2-terminal domain (amino acids 30–263) is essential for actin polymerization in host cytosol (Lasa et al. 1995; Pistor et al. 1995), and can be sufficient for motility if artificially attached to the bacterial membrane (Lasa et al. 1997). However, the NH2-terminal domain does not directly stimulate actin polymerization (Welch et al. 1998).
Actin nucleation at the surface of L. monocytogenes is mediated by the NH2-terminal domain of ActA together with the Arp2/3 complex (Welch et al. 1997, Welch et al. 1998), an evolutionarily conserved host protein complex consisting of the actin-related proteins, (Arp), Arp2 and Arp3, and five other subunits (for review see Machesky and Gould 1999). The Arp2/3 complex is required for bacterial actin-based motility in cell-free extracts (Egile et al. 1999; May et al. 1999; Yarar et al. 1999) and for reconstitution of actin-based motility from purified cytoskeletal proteins (Loisel et al. 1999). Three biochemical activities have been assigned to the Arp2/3 complex: pointed-end capping of actin filaments; cross-linking filaments into branched arrays; and weak nucleating activity thought to occur by stabilization of actin dimers (Mullins et al. 1997, Mullins et al. 1998). In vitro, the nucleating activity of the Arp2/3 complex is dramatically stimulated by full-length ActA and by a truncated derivative consisting only of the mature NH2-terminal domain (Welch et al. 1998). However, the regions within ActA that stimulate the Arp2/3 complex and the contribution of this interaction to motility and pathogenesis, have not been addressed.
In this study, we used deletion and truncation mutations in ActA to define the minimal fragment that nucleates actin polymerization with the Arp2/3 complex and to identify the functional elements within this fragment that contribute to nucleation in vitro and actin-based motility in infected cells. We identified three important regions, each of which shares limited sequence similarity or functional similarity with the Wiscott-Aldrich Syndrome protein (WASP) family of proteins, which has emerged as candidates for mediating actin polymerization at cell membranes by stimulating Arp2/3 complex nucleation activity (for reviews see Machesky and Insall 1999; Welch 1999). By comparing the activities of mutant ActA proteins in vitro with their corresponding phenotypes in cells, we have correlated the biochemical function of each region with its role in actin-based motility.
| Materials and Methods |
|---|
|
|
|---|
|
Allelic Exchange of In-frame ActA Deletions
To replace the 6xHis copy of actA on the 10403S chromosome with deletion alleles, DNA fragments were subcloned into temperature-sensitive vectors pKSV7 (Smith and Youngman 1992), pCON1 (Moors et al. 1999), or pDP-3934 (a derivative of pKSV7 that contains a fragment of L. monocytogenes chromosomal DNA). The resulting plasmids were transformed into 10403S and allelic exchange was performed as described previously (Camilli et al. 1993), yielding strains listed in Table . This strategy allowed the generation of isogenic strains of L. monocytogenes in which each allele was present in a single copy on the chromosome, maintaining all upstream regulatory elements as well as the endogenous transmembrane domain.
To verify that each strain contained the desired deletion, chromosomal DNA was amplified by PCR and the region flanking each deletion was sequenced. To confirm that the desired allele of actA was expressed on the surface of L. monocytogenes, bacteria were grown to mid-log phase in LB medium, washed with PBS, and the surface proteins were extracted by boiling in SDS-PAGE sample buffer as described previously (Brundage et al. 1993; Mourrain et al. 1997). This treatment does not perturb the cell wall of L. monocytogenes and, thus, proteins in the bacterial cytosol are not released. Extracted proteins from cultures with equivalent cell densities (measured by taking the OD at 600 nm) were separated on a 7% SDS-PAGE gel and transferred to Immobilon-P membranes (Millipore). ActA was detected by immunoblotting using rabbit polyclonal antisera (DP-3997) raised against full-length His-tagged ActA.
Expression and Purification of 6xHis-tagged ActA Derivatives
To eliminate the possibility that purified ActA derivatives were contaminated with endogenous ActA, an expression strain of L. monocytogenes was generated in which the entire chromosomal actA gene was deleted. This strain was produced by transforming L. monocytogenes strain DP-L1545 with a vector encoding a derivative of ActA with amino acids 7–633 deleted (pDP-3076) and performing allelic exchange as described above, yielding strain DP-L3935. The parent strain DP-L1545 is an mpl– derivative of SLCC-5764 (a strain that constitutively expresses high levels of ActA), which does not secrete the prfA-regulated metalloprotease that can degrade expressed ActA (Robbins et al. 1999). DP-L3935 was used to express high levels of ActA derivatives.
To isolate 6xHis-tagged ActA derivatives, plasmids encoding these proteins were transformed into DP-L3935, and secreted ActA derivatives were purified using procedures adapted from Welch et al. 1998. ActA deletion derivatives were precipitated from culture supernatant by adding ammonium sulfate to 400 g/liter (
60% saturation). The precipitate was resuspended in wash buffer (20 mM Tris, pH 8.0, 250 mM NaCl, 20 mM imidazole, pH 7.0) and bound to 0.5 ml of Ni-NTA agarose (QIAGEN) per liter equivalent. The resin was washed 10 times with wash buffer and eluted with three bead volumes of wash buffer supplemented with 1 M imidazole, pH 7.0. Eluted proteins were desalted by passing two times over a G-25 (Amersham Pharmacia Biotech) spin column equilibrated in 2 mM Tris, pH 7.6, 0.2 mM CaCl and concentrated using microcon concentrators (Millipore). Protein concentrations were determined in triplicate by the BCA assay (Pierce) using BSA as a standard.
The truncated derivatives of ActA were not precipitated by ammonium sulfate, but were purified from culture supernatants by an alternative method adapted from Cameron et al. 1999. Overnight cultures were diluted 1:100 into modified D10 media supplemented with 10 µg/ml chloramphenicol and incubated for
12 h at 37°C with shaking. Secreted proteins were bound to Q-Sepharose fast flow resin (Amersham Pharmacia Biotech) and eluted with 20 mM Tris, pH 8.0, 1 M NaCl. Proteins in the eluate were bound to NiNTA agarose beads and purified as described above.
Pyrene-Actin Polymerization Assays
Human platelet Arp2/3 complex (Welch and Mitchison 1998), rabbit skeletal muscle actin (Spudich and Watt 1971), and pyrene-labeled actin (Kouyama and Mihashi 1981) were prepared as described previously. Pyrene-actin polymerization assays were performed as described previously (Cooper et al. 1983) with the following modifications. Pyrene-actin and unlabeled actin were mixed in G-buffer (2 mM Tris, pH 7.6, 0.2 mM CaCl, 0.2 mM ATP, 0.2 mM DTT) to generate a 4-µM monomer (G-actin) solution with <20% pyrene-actin. 6 µl of 200 nM Arp2/3 complex or 6 µl of control buffer (20 mM MOPS, pH 7.0, 100 mM KCl, 2 mM MgCl2, 5 mM EGTA, 1 mM EDTA, 0.2 mM ATP, 0.5 mM DTT 10% vol/vol glycerol) was mixed with 6 µl 10x initiation buffer (20 mM MgCl2, 10 mM EGTA, 5 mM ATP) and 18 µl G-buffer or up to 18 µl ActA in G-buffer. This 30-µl solution was mixed with 30 µl of G-actin solution to initiate polymerization. Assembly kinetics were monitored using a Fluorolog 3 fluorometer (Instruments S.A.; excitation wavelength 365 nm, emission wavelength 407 nm) maintained at a temperature of 25°C. The maximal rate of polymerization was determined by calculating the linear regression of the maximal slope using Kaleidagraph software (Synergy Software). Fold stimulation of polymerization by ActA was calculated by dividing the maximal rate of polymerization in the presence of ActA and Arp2/3 complex by the rate of polymerization in the presence of Arp2/3 complex alone. Fold inhibition of polymerization by ActA was calculated by dividing the maximal rate of polymerization in the absence of ActA by the maximal rate in the presence of ActA.
Actin Pelleting Assay
Polymerization of 1 µM G-actin in the presence or absence of 5 µM ActA derivatives was initiated under the conditions described above. Polymerization was allowed to proceed for 10 min at room temperature, and F-actin was pelleted by centrifugation at 313,000 g for 10 min at 4°C. The supernatant was removed and the pellet was suspended in SDS-PAGE sample buffer. Approximately 1/2 of the total pellet fraction and 1/4 of the supernatant fraction were resolved on a 14% SDS-PAGE gel and protein was detected by staining with Coomassie blue.
Immunoprecipitation of the Arp2/3 Complex and ActA
Polyclonal anti-p41 antibody (Yarar et al. 1999) and anti-goat IgG (Jackson ImmunoResearch Laboratories, Inc.) were covalently coupled to Affiprep protein-A support (Bio-Rad Laboratories) by incubation with 20 mM dimethyl pimelimidate (Pierce Chemical Co.). To generate Arp2/3 complex–coated beads, anti-p41 beads were incubated for 30 min at 4°C in human platelet extract that was preincubated with IgG-coated beads for 10 min at 4°C. Platelet extract was prepared by sonicating platelets in high salt sonication buffer (20 mM Tris, pH 8.0, 5 mM EGTA, 1 mM EDTA, 600 mM KCl, 0.1 µg/ml microcystin; Calbiochem), LPC (10 µg/ml leupeptin, pepstatin A, and chymostatin; Chemicon International), followed by centrifugation at 96,000 g for 10 min at 4°C. After incubation in the extract, beads were washed three times with high salt sonication buffer and three times with CoIP buffer (20 mM Hepes, pH 7, 100 mM KCl, 2 mM MgCl2, 5 mM EGTA, 1 mM EDTA, 0.5 mM DTT, 0.2 mM ATP, 10% vol/vol glycerol, 2 mg/ml BSA and LPC). These high salt–washed Arp2/3 complex–coated beads were not contaminated by Arp2/3 binding proteins, as determined by SDS-PAGE and silver staining, nor were they contaminated with the ActA binding proteins actin or VASP, as determined by immunoblotting (data not shown). For ActA binding experiments, 50 µl IgG and Arp2/3-coated beads were incubated with 5 µl of 15-µM ActA derivatives and 100 µl CoIP buffer at room temperature for 30 min. The pellets were washed five times with 50 µl CoIP buffer lacking BSA. Bound proteins were eluted from the beads by the addition of SDS sample buffer, resolved on a 7% SDS-PAGE gel, and were transferred to nitrocellulose membranes; ActA was detected by immunoblotting using a rabbit polyclonal antisera (DP-3997).
Analysis of L. monocytogenes–infected Tissue Culture Cells
HeLa and Potoroo tridactylis kidney epithelia (PtK2) cells were grown on glass coverslips in RPMI 1640 medium (Life Technologies) supplemented with 10% FBS, 2 mM glutamine and 1 mM pyruvate. Subconfluent monolayers were infected with L. monocytogenes as described previously (Smith et al. 1996). For fluorescence staining, HeLa cells were fixed with 3.2% paraformaldehyde at 3.5 h after infection. F-actin was stained with rhodamine-labeled phalloidin (Molecular Probes). VASP was detected with an affinity-purified rabbit polyclonal anti-VASP primary antibody (Smith et al. 1996), followed by an FITC-conjugated donkey anti–rabbit secondary antibody (Jackson ImmunoResearch Laboratories, Inc.). Host and bacterial DNA were stained with DAPI (4,6-diamidino-2-phenylindole). For quantification of bacteria associated with F-actin, infected PtK2 cells were fixed as above and stained with rhodamine-phalloidin and a rabbit polyclonal anti-Listeria antibody (DIFCO Laboratories), followed by an FITC-conjugated donkey anti–rabbit secondary antibody. Infected cells were visualized using a TE300 inverted microscope (Nikon). Images were captured with a CCD camera (Hamamatsu), pseudocolored, and were merged using Phase 3 imaging systems software.
Motility rates were determined in infected PtK2 cells. At 3 h after infection, coverslips were transferred to a heated chamber and maintained in F-12 media (Life Technologies) with 5% FBS and 20 mM Hepes pH 7.0. Phase-contrast images were captured every 10 s for 5 min, and the rate of movement was calculated using Phase 3 imaging systems software. Measurements were terminated if the bacteria stopped moving or encountered the plasma membrane. Plaque assays were performed in monolayers of L2 fibroblast cells as described previously (Sun et al. 1990; Jones and Portnoy 1994). Plaque size was determined by capturing images using a digital camera and measuring the diameter of at least 15 plaques per experiment using Canvas (Deneba Software). Mutant plaque size was compared with wild type for each experiment.
| Results |
|---|
|
|
|---|
|
|
|
Three Regions within the NH2-terminal Domain of ActA Have Distinct Functions in Actin Nucleation with the Arp2/3 Complex
To better assess the contribution of each region within the NH2-terminal domain of ActA to actin nucleation, we generated and purified a series of 6xHis-tagged in-frame deletion derivatives of ActA (Fig. 3, a and b). The capacity of these derivatives to nucleate polymerization with the Arp2/3 complex was determined using the pyrene-actin polymerization assay. Consistent with the results of the truncation analysis, a derivative lacking the entire NH2-terminal domain (
31-262) was unable to enhance nucleation when present at an equal concentration (Fig. 4 a) or at a 10-fold molar excess (Fig. 4 d) with respect to the Arp2/3 complex. Another derivative (
202-263), which based on the truncation analysis was missing amino acids that are not critical for nucleation, was as active as full-length ActA (Fig. 4 a), indicating that large deletions within this domain can be tolerated without reducing activity.
|
|
136-165) had virtually no stimulatory effect on polymerization kinetics when added at equimolar concentrations with the Arp2/3 complex (Fig. 4 b). Other ActA derivatives containing larger deletions encompassing this region (
136-200,
60-165, and
31-165) exhibited comparable activity at this same concentration (Fig. 4 b). To more specifically assess the function of the cofilin homology sequence, a derivative was constructed in which the five basic residues at the core of this sequence were removed (
146-150; Fig. 3 a). The activity of this protein was identical to those with larger deletions encompassing this region (Fig. 4 b). Because of the relatively conservative nature of its lesion,
146-150 was chosen for further analysis. Increasing the concentration of
146-150 to 10-fold molar excess over the Arp2/3 complex resulted in an increase in its nucleating activity relative to lower concentrations (Fig. 4 d), although the degree of stimulation was far less than that of the full-length protein. This indicates that
146-150 retains some concentration-dependent nucleating activity.
An ActA derivative harboring a deletion of the acidic stretch (
31-58) was able to accelerate nucleation when added at equal concentrations relative to the Arp2/3 complex, but was less active than full-length ActA (Fig. 4 c). Increasing the concentration of
31-58 to a 10-fold excess over the Arp2/3 complex resulted in a higher degree of stimulation (Fig. 4 d). At both the lower and higher concentrations,
31-58 was less potent than the full-length protein, but more potent than mutants lacking the cofilin homology sequence. Finally, a derivative missing the putative actin-binding region (
60-101; Lasa et al. 1997; Cicchetti et al. 1999) caused virtually no enhancement of polymerization kinetics when combined at equal concentrations (Fig. 4 c) or a 10-fold excess relative to the Arp2/3 complex (Fig. 4 d). At both concentrations, the activity of
60-101 was comparable to that of
31-262 (Fig. 4c and Fig. d), which is missing the entire NH2-terminal domain and is essentially inactive.
The relative activities of the derivatives missing the cofilin homology sequence (
146-150), the putative actin-binding region (
60-101), and the acidic stretch (
31-58) were quantified and compared. For increasing concentrations of each derivative, the fold stimulation of the maximum rate of polymerization with the Arp2/3 complex was plotted versus the concentration of the derivative (Fig. 5). Full-length ActA stimulated the maximal rate of polymerization up to 25-fold, reaching saturation at a concentration 10 times that of the Arp2/3 complex. In contrast, at concentrations 100 times that of Arp2/3 complex,
146-150 stimulated polymerization 5-fold (1/5 of the maximum achieved by full-length),
60-101 stimulated polymerization 2-fold (1/12 that of full-length), and
31-58 stimulated polymerization 13-fold (1/2 that of full-length). Thus, the cofilin homology sequence and the acidic stretch are important for stimulating nucleation, and the putative actin-binding region plays an essential role in this process in vitro.
ActA Binds Actin Monomer through Its Actin-binding Region
To confirm that ActA binds to actin monomer (Lasa et al. 1997; Cicchetti et al. 1999), and to assess the location of the actin-binding region, we evaluated the ability of the full-length ActA and selected truncation and deletion derivatives to inhibit the rate of actin polymerization (Fig. 6 a). Increasing concentrations of the full-length ActA included in the pyrene-actin assay (in the absence of the Arp2/3 complex) caused a dose-dependent reduction in the maximum rate of polymerization (Fig. 6 a), but did not affect the steady state amount of actin polymer (not shown). Deletion of the NH2-terminal domain of ActA (
31-262) or the putative actin-binding region (
60-101) rendered ActA unable to inhibit actin polymerization even at a two-fold molar excess relative to actin. In contrast, a truncation derivative consisting of the acidic and actin-binding regions (A101) and the deletion derivatives, missing the acidic stretch (
31-58) and the cofilin homology region (
136-165), was still able to inhibit actin polymerization. Deletion of the acidic stretch slightly enhanced the ability of ActA to inhibit actin polymerization, whereas deletion of the cofilin homology sequence slightly retarded this activity. The inhibition of polymerization was due to actin monomer binding and not filament capping because derivatives did not inhibit filament depolymerization in a pyrene-actin depolymerization assay (data not shown). These results were confirmed by measuring the ability of ActA derivatives to inhibit polymerization when included at a five-fold molar excess relative to actin in a pelleting assay (Fig. 6 b). Our results demonstrate that ActA binds to the actin monomer through an actin-binding region located between amino acids 60 and 101. Taken together with the activity of
60-101 in the presence of the Arp2/3 complex, these data indicate that actin monomer binding is critical for stimulating actin nucleation with the Arp2/3 complex in vitro.
|
31-262 derivative lacking the entire NH2-terminal domain did not bind to the complex, indicating that the NH2-terminal domain is required for this interaction. Derivatives missing the cofilin homology sequence (
136-165), the actin-binding region (
60-101), and the acidic stretch (
31-58) all bound to the Arp2/3 complex. These data suggest that no single region within the NH2-terminal domain is solely responsible for binding to the complex.
|
|
|
|
7-632,
31-165,
136-200,
60-165, and
146-150) were motile or capable of polymerizing actin in these cell types, leading to the accumulation of microcolonies near the center of the cell. Intermediate phenotypes were exhibited by mutants missing the acidic domain (
31-58; 73% F-actin positive; 12% with tails), the actin-binding region (
60-101; 75% F-actin positive; 30% with tails), or the region COOH-terminal to the cofilin homology sequence (
202-263; 99% F-actin positive; 28% with tails). These data suggest that the cofilin homology sequence is essential for actin polymerization in cells, whereas the other regions contribute to both actin polymerization and motility.
For those mutant strains that formed actin comet tails in infected PtK2 cells, rates of intracellular motility were determined using time-lapse phase microscopy (Table ). Compared with wild-type L. monocytogenes,
202-263 (4% reduced),
60-101 (18% reduced), and
31-58 (34% reduced) mutants exhibited similar or moderately lower mean motility rates. These results suggest that once bacteria are able to initiate actin polymerization, deletions within the NH2-terminal region of ActA cause only small changes in the velocity of movement.
actA Alleles Affect the Ability of L. monocytogenes to Spread from Cell to Cell
To correlate the effects of actA mutations on actin-based motility with their effects on L. monocytogenes cell-to-cell spread, mutant strains were tested for their ability to form a plaque in a monolayer of mouse L2 fibroblast cells (Table ). Wild-type L. monocytogenes (defined as 100% plaque size) and the
202-263 mutant formed nearly equivalent-sized plaques. Mutants that expressed derivatives lacking the cofilin homology sequence (
7-633,
31-165,
136-200,
60-165,
136-165, and
146-150), which were unable to polymerize actin in cells, were unable to form plaques. Mutants lacking the actin-binding region (
60-101) or the acidic stretch (
31-58) exhibited a reduced mean plaque size. Thus, there is a good correlation between the capacity of the mutants to undergo actin-based motility and their ability to spread from cell to cell.
| Discussion |
|---|
|
|
|---|
ActA Mimics WASP Family Proteins
L. monocytogenes capitalizes on a host mechanism of actin-based motility to spread from cell to cell, perhaps by mimicking the function of endogenous proteins that promote actin nucleation. One such class of host factors is the WASP family of proteins (including WASP, N-WASP, Las17p/Bee1p, and Scar/WAVE), which stimulate actin nucleation with the Arp2/3 complex in vitro (Egile et al. 1999; Machesky et al. 1999; Rohatgi et al. 1999; Winter et al. 1999; Yarar et al. 1999) and direct actin-based motility in cell cytoplasm (Suzuki et al. 1998; Egile et al. 1999; Yarar et al. 1999). We found that the minimal fragment of ActA that retains full activity in vitro can be divided into three regions, which have counterparts in the minimal active fragment of WASP family proteins (Higgs et al. 1999; Machesky et al. 1999; Rohatgi et al. 1999; Winter et al. 1999). These include an acidic stretch and a cofilin homology sequence that share limited sequence similarity with corresponding regions in WASP family proteins (Bi and Zigmond 1999), as well as an actin monomer–binding region that is not similar in sequence to the monomer-binding WH2 (WASP homology 2 or Verprolin homology) domain of WASP proteins. This correspondence suggests that ActA and WASP family proteins function by similar mechanisms.
The Cofilin Homology Sequence Is Critical for Actin Nucleation In Vitro and in Cells
An ActA derivative lacking only five amino acids at the core of the cofilin homology sequence (
146-150) is severely compromised in its capacity to stimulate nucleation with the Arp2/3 complex, but a mutant that lacks this entire region (
136-165) can still bind the complex. Similarly, a derivative of N-WASP, lacking the cofilin homology sequence, has a dramatically reduced ability to stimulate actin nucleation (Rohatgi et al. 1999), and exhibits a slightly reduced capacity to bind to the Arp2/3 complex (Banzai et al. 2000). Therefore, this sequence element plays a critical role in stimulating nucleation in both proteins, perhaps by participating in binding to the Arp2/3 complex and/or by inducing a conformational change in the complex that facilitates nucleation.
Consistent with the severe defects exhibited by the
146-150 derivative in vitro, L. monocytogenes mutants expressing
146-150 on their surface do not associate with actin in HeLa or PtK2 cells and do not form plaques in an L2 cell monolayer. However, a small percentage of L. monocytogenes that express
146-150 are capable of associating with actin in MDCK and J774 cells (Lauer, P., J. Theriot, and D. Portnoy, unpublished results). In addition, mutants that overexpress this derivative form actin clouds, but not actin tails, in Xenopus laevis egg extract (Lasa et al. 1997). The discrepancy between the behaviors of this mutant in different cytoplasmic environments may reflect differences in the concentration of host cytoskeletal proteins. Nevertheless, the mutant phenotypes indicate that the cofilin homology sequence is critical for pathogenesis and, while not necessary for actin nucleation, is required to achieve the threshold of activity needed to initiate actin-based motility.
The Acidic Stretch Plays a Nonessential Role in Nucleation and Intracellular Motility
ActA fragments consisting only of the acidic stretch and actin-binding region possess stimulatory activity, indicating that these elements play a role in nucleation. Moreover, a derivative lacking the acidic stretch (
31-58) retains the capacity to bind the Arp2/3 complex and exhibits a modest reduction in maximum activity compared with full-length ActA in vitro. This suggests that the acidic stretch may function with the cofilin homology sequence to promote nucleation by facilitating a productive interaction with the Arp2/3 complex. Interestingly, the acidic stretch in N-WASP is essential for Arp2/3 complex binding and for stimulating nucleation (Rohatgi et al. 1999), suggesting that ActA may exhibit more redundancy in its binding and activation mechanism.
Compared with the wild type, mutants expressing
31-58 exhibit a diminished percentage of bacteria that polymerize actin, a reduced percentage of moving bacteria, a reduced mean rate of motility, and an impaired capacity to spread from cell to cell. These phenotypes point to a direct correlation between the nucleation activity of the Arp2/3 complex with ActA in vitro and the efficiency of actin polymerization and L. monocytogenes motility in cells.
The Actin-binding Region Is Necessary for Nucleation In Vitro but Not in Cells
The results of our study confirm the actin monomer–binding activity of ActA (Lasa et al. 1997; Cicchetti et al. 1999) and extend previous studies by addressing the role of monomer binding in nucleation and motility. An ActA derivative missing the monomer-binding region was virtually unable to stimulate Arp2/3-mediated nucleation in vitro, suggesting that actin binding is critical for nucleation in the context of purified proteins. Similarly, the actin binding WH2 domain of N-WASP is critical for stimulating nucleation (Rohatgi et al. 1999). The essential function of this region may be to position an actin monomer in close proximity to the Arp2/3 complex, forming a trimeric nucleus (Fig. 10) consisting of the two actin-related proteins in the complex and the actin monomer bound to ActA.
|
The Role of Actin Nucleation by ActA and the Arp2/3 Complex in L. monocytogenes Motility
We propose a model in which actin nucleation at the L. monocytogenes surface results from an interaction between monomeric actin and the Arp2/3 complex with at least three regions within the NH2-terminal domain of ActA (Fig. 10). Interaction of the Arp2/3 complex with the cofilin homology sequence and the acidic stretch may induce a conformational change in the complex that promotes nucleation. Nucleation may also require correct positioning of an actin monomer in close proximity to the Arp2/3 complex, a function provided by the actin-binding region in ActA or, alternatively, by host proteins such as profilin, which are associated with ActA in cell cytoplasm. Bound actin monomer would complete a nucleation site, whose formation would be unfavorable in the absence of ActA, because the Arp2/3 complex alone is thought to nucleate by binding rare and unstable actin dimers (Mullins et al. 1998). Elongation of newly formed filaments at the bacterial surface may be facilitated by profilin and VASP, which enhance bacterial motility in a system of purified proteins (Loisel et al. 1999). The similarities between ActA and WASP family proteins suggest that they represent a fascinating example of convergent evolution. Interestingly, the unrelated bacterial pathogen Shigella flexneri initiates actin-based motility by recruiting and activating N-WASP at its surface rather than mimicking its activity (Suzuki et al. 1998; Egile et al. 1999). Further understanding of the mechanism of ActA-Arp2/3–mediated actin nucleation will lead us to a greater understanding of cell motility and the mechanisms of microbial pathogenesis.
| Acknowledgments |
|---|
This work was supported by US Public Health Service grants AI29619 (to D.A. Portnoy), and GM59609 (to M.D. Welch). M.D. Welch is a Leukemia Society of America Special Fellow.
Submitted: 20 January 2000
Revised: 13 June 2000
Accepted: 15 June 2000
Abbreviations used in this paper: Arp, actin-related protein; F-actin, filamentous actin; G-actin monomeric actin; LB, Luria-Bertani; N-WASP, neuronal WASP; PtK2 Potoroo tridactylis kidney epithelial; VASP, vasodilator-stimulated phosphoprotein; WASP, Wiscott-Aldrich syndrome protein.
| References |
|---|
|
|
|---|
Banzai Y. Miki H. Yamaguchi H. Takenawa T. Essential role of neural Wiskott-Aldrich syndrome protein in neurite extension in PC12 cells and rat hippocampal primary culture cells, J. Biol. Chem, 275, 2000, 11987–11992.
Bachmann C. Fischer L. Walter U. Reinhard M.. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation, J. Biol. Chem, 274, 1999, 23549–23557.
Bi E. Zigmond S.H.. Actin polymerizationwhere the WASP stings, Curr. Biol, 9, 1999, R160–R163.[Medline]
Brundage R.A. Smith G.A. Camilli A. Theriot J.A. Portnoy D.A.. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells, Proc. Natl. Acad. Sci, USA. 90, 1993, 11890–11894.[Medline]
Cameron L.A. Footer M.J. van Oudenaarden A. Theriot J.A.. Motility of ActA protein-coated microspheres driven by actin polymerization, Proc. Natl. Acad. Sci. USA, 96, 1999, 4908–4913.
Camilli A. Tilney L.G. Portnoy D.A.. Dual roles of plcA in Listeria monocytogenes pathogenesis, Mol. Microbiol, 8, 1993, 143–157.[Medline]
Chakraborty T. Ebel F. Domann E. Niebuhr K. Gerstel B. Pistor S. Temm-Grove C.J. Jockusch B.M. Reinhard M. Walter U.. A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells, EMBO (Eur. Mol. Biol. Organ.) J, 14, 1995, 1314–1321.[Medline]
Chou P.Y. Fasman G.D.. Prediction of protein conformation, Biochemistry, 13, 1974, 222–245.[Medline]
Cicchetti G. Maurer P. Wagener P. Kocks C.. Actin and phosphoinositide binding by the ActA protein of the bacterial pathogen Listeria monocytogenes, J. Biol. Chem, 274, 1999, 33616–33626.
Cooper J.A. Walker S.B. Pollard T.D.. Pyrene actindocumentation of the validity of a sensitive assay for actin polymerization, J. Muscle Res. Cell Motil, 4, 1983, 253–262.[Medline]
Domann E. Wehland J. Rohde M. Pistor S. Hartl M. Goebel W. Leimeister-Wachter M. Wuenscher M. Chakraborty T.. A novel bacterial virulence gene in Listeria monocytogenes required for host cell microfilament interaction with homology to the proline-rich region of vinculin, EMBO (Eur. Mol. Biol. Organ.) J, 11, 1992, 1981–1990.[Medline]
Egile C. Loisel T.P. Laurent V. Li R. Pantaloni D. Sansonetti P.J. Carlier M.F.. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility, J. Cell Biol, 146, 1999, 1319–1332.
Gertler F.B. Niebuhr K. Reinhard M. Wehland J. Soriano P.. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics, Cell, 87, 1996, 227–239.[Medline]
Higgs H.N. Blanchoin L. Pollard T.D.. Influence of the C terminus of Wiskott-Aldrich Syndrome protein (WASp) and the Arp2/3 complex on actin polymerization, Biochemistry, 38, 1999, 15212–15222.[Medline]
Horton R.M. Cai Z. Ho S.N. Pease L.R.. Gene splicing by overlap extensiontailor-made genes using the polymerase chain reaction, Biotechniques, 8, 1990, 528–535.[Medline]
Ireton K. Cossart P.. Host-pathogen interactions during entry and actin-based movement of Listeria monocytogenes, Annu. Rev. Genet, 31, 1997, 113–138.[Medline]
Jones S. Portnoy D.A.. Small plaque mutants, Methods Enzymol, 236, 1994, 526–531.[Medline]
Kang F. Laine R.O. Bubb M.R. Southwick F.S. Purich D.L.. Profilin interacts with the Gly-Pro-Pro-Pro-Pro-Pro sequences of vasodilator-stimulated phosphoprotein VASPimplications for actin-based Listeria motility, Biochemistry, 36, 1997, 8384–8392.[Medline]
Kocks C. Gouin E. Tabouret M. Berche P. Ohayon H. Cossart P.. L. monocytogenes-induced actin assembly requires the actA gene product, a surface protein, Cell, 68, 1992, 521–531.[Medline]
Kouyama T. Mihashi K.. Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin, Eur. J. Biochem, 114, 1981, 33–38.[Medline]
Lasa I. David V. Gouin E. Marchand J.B. Cossart P.. The amino-terminal part of ActA is critical for the actin-based motility of Listeria monocytogenes; the central proline-rich region acts as a stimulator, Mol. Microbiol, 18, 1995, 425–436.[Medline]
Lasa I. Gouin E. Goethals M. Vancompernolle K. David V. Vandekerckhove J. Cossart P.. Identification of two regions in the N-terminal domain of ActA involved in the actin comet tail formation by Listeria monocytogenes, EMBO (Eur. Mol. Biol. Organ.) J, 16, 1997, 1531–1540.[Medline]
Loisel T.P. Boujemaa R. Pantaloni D. Carlier M.F.. Reconstitution of actin-based motility of Listeria and Shigella using pure proteins, Nature, 401, 1999, 613–616.[Medline]
Machesky L.M. Gould K.L.. The Arp2/3 complexa multifunctional actin organizer, Curr. Opin. Cell Biol, 11, 1999, 117–121.[Medline]
Machesky L.M. Insall R.H.. Signaling to actin dynamics, J. Cell Biol, 146, 1999, 267–272.
Machesky L.M. Mullins R.D. Higgs H.N. Kaiser D.A. Blanchoin L. May R.C. Hall M.E. Pollard T.D.. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex, Proc. Natl. Acad. Sci. USA, 96, 1999, 3739–3744.
May R.C. Hall M.E. Higgs H.N. Pollard T.D. Chakraborty T. Wehland J. Machesky L.M. Sechi A.S.. The Arp2/3 complex is essential for the actin-based motility of Listeria monocytogenes, Curr. Biol, 9, 1999, 759–762.[Medline]
Mogilner A. Oster G.. Cell motility driven by actin polymerization, Biophys. J, 71, 1996, 3030–3045.[Medline]
Moors M.A. Auerbuch V. Portnoy D.A.. Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N-end rule pathway, Cell. Microbiol., 1, 1999, 249–258.[Medline]
Mourrain P. Lasa I. Gautreau A. Gouin E. Pugsley A. Cossart P.. ActA is a dimer, Proc. Natl. Acad. Sci. USA., 94, 1997, 10034–10039.
Mullins R.D. Stafford W.F. Pollard T.D.. Structure, subunit topology, and actin-binding activity of the Arp2/3 complex from Acanthamoeba, J. Cell Biol, 136, 1997, 331–343.
Mullins R.D. Heuser J.A. Pollard T.D.. The interaction of Arp2/3 complex with actinnucleation, high affinity pointed end capping, and formation of branching networks of filaments, Proc. Natl. Acad. Sci., 95, 1998, 6181–6186.
Niebuhr K. Ebel F. Frank R. Reinhard M. Domann E. Carl U.D. Walter U. Gertler F.B. Wehland J. Chakraborty T.. A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family, EMBO (Eur. Mol. Biol. Organ.) J, 16, 1997, 5433–5444.[Medline]
Pistor S. Chakraborty T. Niebuhr K. Domann E. Wehland J.. The ActA protein of Listeria monocytogenes acts as a nucleator inducing reorganization of the actin cytoskeleton, EMBO (Eur. Mol. Biol. Organ.) J, 13, 1994, 758–763.[Medline]
Pistor S. Chakraborty T. Walter U. Wehland J.. The bacterial actin nucleator protein ActA of Listeria monocytogenes contains multiple binding sites for host microfilament proteins, Curr. Biol, 5, 1995, 517–525.[Medline]
Reinhard M. Halbrugge M. Scheer U. Wiegand C. Jockusch B.M. Walter U.. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts, EMBO (Eur. Mol. Biol. Organ.) J, 11, 1992, 2063–2070.[Medline]
Reinhard M. Giehl K. Abel K. Haffner C. Jarchau T. Hoppe V. Jockusch B.M. Walter U.. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins, EMBO (Eur. Mol. Biol. Organ.) J, 14, 1995, 1583–1589.[Medline]
Robbins J.R. Barth A.I. Marquis H. de Hostos E.L. Nelson W.J. Theriot J.A.. Listeria monocytogenes exploits normal host cell processes to spread from cell to cell, J. Cell Biol, 146, 1999, 1333–1350.
Rohatgi R. Ma L. Miki H. Lopez M. Kirchhausen T. Takenawa T. Kirschner M.W.. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly, Cell, 97, 1999, 221–231.[Medline]
Sanger J.M. Sanger J.W. Southwick F.S.. Host cell actin assembly is necessary and likely to provide the propulsive force for intracellular movement of Listeria monocytogenes, Infect. Immun, 60, 1992, 3609–3619.
Smith G.A. Portnoy D.A. Theriot J.A.. Asymmetric distribution of the Listeria monocytogenes ActA protein is required and sufficient to direct actin-based motility, Mol. Microbiol, 17, 1995, 945–951.[Medline]
Smith G.A. Theriot J.A. Portnoy D.A.. The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin, J. Cell Biol, 135, 1996, 647–660.
Smith K. Youngman P.. Use of a new integrational vector to investigate compartment-specific expression of the Bacillus subtilis spoIIM gene, Biochimie, 74, 1992, 705–711.[Medline]
Spudich J.A. Watt S.. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin, J. Biol. Chem, 246, 1971, 4866–4871.
Sun A.N. Camilli A. Portnoy D.A.. Isolation of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread, Infect. Immun, 58, 1990, 3770–3778.
Suzuki T. Miki H. Takenawa T. Sasakawa C.. Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri, EMBO (Eur. Mol. Biol. Organ.) J, 17, 1998, 2767–2776.[Medline]
Theriot J.A. Mitchison T.J. Tilney L.G. Portnoy D.A.. The rate of actin-based motility of intracellular Listeria monocytogenes equals the rate of actin polymerization, Nature, 357, 1992, 257–260.[Medline]
Theriot J.A. Rosenblatt J. Portnoy D.A. Goldschmidt-Clermont P.J. Mitchison T.J.. Involvement of profilin in the actin-based motility of L. monocytogenes in cells and in cell-free extracts, Cell, 76, 1994, 505–517.[Medline]
Tilney L.G. Portnoy D.A.. Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes, J. Cell Biol, 109, 1989, 1597–1608.
Welch M.D.. The world according to Arpregulation of actin nucleation by the Arp2/3 complex, Trends Cell Biol, 9, 1999, 423–427.[Medline]
Welch M.D. Mitchison T.J.. Purification and assay of the platelet Arp2/3 complex, Methods Enzymol, 298, 1998, 52–61.[Medline]
Welch M.D. Iwamatsu A. Mitchison T.J.. Actin polymerization is induced by Arp2/3 protein complex at the surface of Listeria monocytogenes, Nature, 385, 1997, 265–269.[Medline]
Welch M.D. Rosenblatt J. Skoble J. Portnoy D.A. Mitchison T.J.. Interaction of human Arp2/3 complex and the Listeria monocytogenes ActA protein in actin filament nucleation, Science, 281, 1998, 105–108.
Winter D. Lechler T. Li R.. Activation of the yeast Arp2/3 complex by Bee1p, a WASP-family protein, Curr. Biol, 9, 1999, 501–504.[Medline]
Wirth R. An F.Y. Clewell D.B.. Highly efficient protoplast transformation system for Streptococcus faecalis and a new Escherichia coli-S. faecalis shuttle vector, J. Bacteriol, 165, 1986, 831–836.
Yarar D. To W. Abo A. Welch M.D.. The Wiskott-Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex, Curr. Biol, 9, 1999, 555–558.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|